Cargando…
DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration
Deleted in Liver Cancer 1 (DLC1) is a RhoGAP-containing tumor suppressor that associates with various types of cancer. Although DLC2 shares a similar domain structure with that of DLC1, the function of DLC2 is not well characterized. Here, we describe the expression and ablation of DLC2 in mice usin...
Autores principales: | Lin, Yuan, Chen, Nein-Tsu, Shih, Yi-Ping, Liao, Yi-Chun, Xue, Ling, Lo, Su Hao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874629/ https://www.ncbi.nlm.nih.gov/pubmed/20208559 http://dx.doi.org/10.1038/onc.2010.54 |
Ejemplares similares
-
The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007) -
Endothelial DLC1 is dispensable for liver and kidney function in mice
por: Tan, Ying, et al.
Publicado: (2020) -
Cell Heterogeneity
Revealed by On-Chip Angiogenic
Endothelial Cell Migration
por: Xie, Tianze, et al.
Publicado: (2020) -
DLC1 inhibits colon adenocarcinoma cell migration by promoting secretion of the neurotrophic factor MANF
por: Chu, Yi-Min, et al.
Publicado: (2022) -
Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell
Morphology and
Migration
por: Kim, Tai Young, et al.
Publicado: (2008)